Effective dose to immune cells combined with platelet-to-lymphocyte ratio predicts lymphopenia and prognosis in unresectable locally advanced non-small cell lung cancer.

Front Immunol · 2025 · PMC12504879 · PMID 41070362

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an interesting trendno p-value reported

An interesting trend was observed within the low-risk group: patients with high EDIC but low PLR (low-risk 2 subgroup) had poorer outcomes than those with low EDIC but high PLR (low-risk 3 subgroup).

also in 1,024 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.